{"product_id":"association-for-molecular-pathology-annual-meeting-expo-2022","title":"Association for Molecular Pathology Annual Meeting \u0026 Expo 2022","description":"\u003ch3\u003eAssociation for Molecular Pathology Annual Meeting \u0026amp; Expo 2022\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 71 videos, size: 38.4 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: molecular pathologists, clinical laboratory directors, medical geneticists, oncologists, infectious disease specialists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"573\" data-start=\"0\"\u003eThe Association for Molecular Pathology (AMP) Annual Meeting \u0026amp; Expo 2022 is a premier event bringing together professionals from around the world to advance the science, technology, and practice of molecular pathology. This comprehensive program features cutting-edge research presentations, expert-led sessions, and hands-on workshops, covering the latest innovations in diagnostics, genomics, and molecular medicine. Attendees will explore emerging technologies, clinical applications, and industry trends shaping the future of precision medicine.\u003c\/p\u003e\n\u003cp data-end=\"600\" data-start=\"575\"\u003e\u003cstrong data-end=\"598\" data-start=\"575\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1008\" data-start=\"601\"\u003e\n\u003cli data-end=\"670\" data-start=\"601\"\u003e\n\u003cp data-end=\"670\" data-start=\"603\"\u003eLatest advances in molecular diagnostics and genomic technologies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"768\" data-start=\"671\"\u003e\n\u003cp data-end=\"768\" data-start=\"673\"\u003eApplications of molecular pathology in oncology, infectious diseases, and inherited disorders\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"845\" data-start=\"769\"\u003e\n\u003cp data-end=\"845\" data-start=\"771\"\u003eBest practices for integrating molecular testing into clinical workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"935\" data-start=\"846\"\u003e\n\u003cp data-end=\"935\" data-start=\"848\"\u003eRegulatory, reimbursement, and quality assurance considerations in molecular medicine\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1008\" data-start=\"936\"\u003e\n\u003cp data-end=\"1008\" data-start=\"938\"\u003eInsights into future trends and innovations in precision diagnostics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1029\" data-start=\"1010\"\u003e\u003cstrong data-end=\"1027\" data-start=\"1010\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1430\" data-start=\"1030\"\u003e\n\u003cli data-end=\"1107\" data-start=\"1030\"\u003e\n\u003cp data-end=\"1107\" data-start=\"1032\"\u003e\u003cstrong data-end=\"1042\" data-start=\"1032\"\u003eEvent:\u003c\/strong\u003e Association for Molecular Pathology Annual Meeting \u0026amp; Expo 2022\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1186\" data-start=\"1108\"\u003e\n\u003cp data-end=\"1186\" data-start=\"1110\"\u003e\u003cstrong data-end=\"1121\" data-start=\"1110\"\u003eFormat:\u003c\/strong\u003e In-person conference with select virtual participation options\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1305\" data-start=\"1187\"\u003e\n\u003cp data-end=\"1305\" data-start=\"1189\"\u003e\u003cstrong data-end=\"1212\" data-start=\"1189\"\u003eProgram Highlights:\u003c\/strong\u003e Scientific sessions, poster presentations, industry exhibits, and networking opportunities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1430\" data-start=\"1306\"\u003e\n\u003cp data-end=\"1430\" data-start=\"1308\"\u003e\u003cstrong data-end=\"1327\" data-start=\"1308\"\u003eTopics Covered:\u003c\/strong\u003e Next-generation sequencing, liquid biopsy, biomarkers, bioinformatics, and molecular test validation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1758\" data-start=\"1432\"\u003e\u003cstrong data-end=\"1453\" data-start=\"1432\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eMolecular pathologists, clinical laboratory directors, medical geneticists, oncologists, infectious disease specialists, researchers, and laboratory professionals. It is also valuable for biotechnology and pharmaceutical industry members, regulatory professionals, and trainees in molecular medicine.\u003c\/p\u003e\n\u003cp data-end=\"2156\" data-is-last-node=\"\" data-is-only-node=\"\" data-start=\"1760\"\u003e\u003cstrong data-end=\"1774\" data-start=\"1760\"\u003eWhy Attend\u003c\/strong\u003e\u003cbr\u003eThis meeting provides a unique platform to connect with global leaders in molecular pathology, gain firsthand knowledge of emerging technologies, and explore innovative solutions for improving patient care. Attendees will leave with enhanced technical skills, updated scientific insights, and a stronger professional network in the rapidly evolving field of precision medicine.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eA Dive into NGS Test Development and Bioinformatics Pipelines.mp4\u003cbr\u003eA Multidisciplinary Perspective on the Latest Advancements in Precision Medicine.mp4\u003cbr\u003eAccelerating NGS Workflows in Oncology Clinical Research From Genomic Data to Insights.mp4\u003cbr\u003eAMP Lunch and Learn on our New Resources.mp4\u003cbr\u003eAMP Working Group Update of Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.mp4\u003cbr\u003eApplied Biosystems QuantStudio Absolute Q Digital PCR System.mp4\u003cbr\u003eApplied Biosystems QuantStudio Real Time PCR Ecosystem, Thermo Fisher Scientific’s.mp4\u003cbr\u003eAutomated Classification of Solid Tumor and Hematologic Malignancies Using Artificial Intelligence.mp4\u003cbr\u003eBetter Genetic Answers in a Streamlined Analysis Workflow.mp4\u003cbr\u003eBiomarker Testing in Advanced Prostate Cancer to Help Inform Clinical Decisions.mp4\u003cbr\u003eCase Studies in Genetics and Infectious Diseases.mp4\u003cbr\u003eCase Studies in Hematopathology.mp4\u003cbr\u003eCase Studies in Solid Tumors I.mp4\u003cbr\u003eCase Studies in Solid Tumors II.mp4\u003cbr\u003eCelebrating lO Years at Innovation.mp4\u003cbr\u003eChallenges and Considerations of Germline Testing In the Era of Tumor Sequencing.mp4\u003cbr\u003eClassification Updates in Lymphoid Malignancies.mp4\u003cbr\u003eClassification Updates in Myeloid Malignancies.mp4\u003cbr\u003eComprehensive Assessment of HRD from Next-Generation Sequencing and Optical Genome Mapping.mp4\u003cbr\u003eComprehensive Genomic Profiling from Liquid Biopsy Samples.mp4\u003cbr\u003eDemocratizing NGS sample prep how to achieve reliable, robust, and scalable automation.mp4\u003cbr\u003eDeveloping the 5 minute point-of-care PCR test a technology revolutionizing molecular diagnostics.mp4\u003cbr\u003eDevelopment and Implementation of an Automated and Highly Accurate Reporting Process for NGS-based Clonality Testing.mp4\u003cbr\u003eDiagnostic and Therapeutic Updates Of Cancer Predisposition.mp4\u003cbr\u003eEfforts toward a Diverse and Inclusive Human Genome Reference.mp4\u003cbr\u003eFrontline Multiplex Panel Testing and Reimbursement Challenges – From Respiratory to Gastrointestinal.mp4\u003cbr\u003eGenexus myeloid testing at FHCC.mp4\u003cbr\u003eGenomic Data Quality Connecting the Dots Between Bioinformatics and Physical Materials.mp4\u003cbr\u003eGenomic Medicine and the Primary Care Physician.mp4\u003cbr\u003eHigh-Throughput Sequencing Of TCR Gene Rearrangements As A Useful Tool For Identifying And Tracking Minimal Measurable.mp4\u003cbr\u003eImplementation of Pharmacogenomics A New Frontier in Patient Care.mp4\u003cbr\u003eImproving Access to Precision Oncology Through In-House Plasma Biopsy Testing.mp4\u003cbr\u003eIntroduction to GUIDANCE UTI.mp4\u003cbr\u003eKingFisher versatility through sample type.mp4\u003cbr\u003eLeaders in Decision Medicine.mp4\u003cbr\u003eLessons Learned from AMP’s Variant Interpretation Challenges.mp4\u003cbr\u003eLiquid Biopsy – Improving Patient Access to Precision Oncology Through Centralized Services and Kitted Solutions.mp4\u003cbr\u003eMaximizing Detection Of Pathogenic Structural Variants Across Hematological Malignancies With Optical Genome Mapping.mp4\u003cbr\u003eMicrobiome in Health and Disease.mp4\u003cbr\u003eMitigating variability in somatic variant interpretation.mp4\u003cbr\u003eMolecular Controls for Emerging Diseasez the Need for Rapic Development and Harmonization.mp4\u003cbr\u003eMolecular Updates The 2021 WHO Classification of Tumors of the Central Nervous System.mp4\u003cbr\u003eNegotiating in a Hostage Situation Tips to Keep Your Lab Financially Solvent During COVID-19 and the Next Pandemic.mp4\u003cbr\u003eOGT Workshop.mp4\u003cbr\u003eOn the road to accurate and precise ctDNA testing.mp4\u003cbr\u003eOncomine Clinical Research Grants Awardees 2022 Autumn Call.mp4\u003cbr\u003eOnkoSight DNA + RNA CGP Panel Implementation and Clinical Practice.mp4\u003cbr\u003eOptimizing Comprehensive Genomic Profiling Pathways with Reflex Testing in NSCLC.mp4\u003cbr\u003eOptimizing FFPE Extraction for Methylation Array and Sequencing Assays.mp4\u003cbr\u003ePersonal Genome Diagnostics.mp4\u003cbr\u003ePlatform Presentations of Selected Genetics Abstracts.mp4\u003cbr\u003ePlatform Presentations of Selected Hematopathology Abstracts.mp4\u003cbr\u003ePlatform Presentations of Selected Infectious Diseases Abstracts.mp4\u003cbr\u003ePlatform Presentations of Selected Informatics Abstracts.mp4\u003cbr\u003ePlatform Presentations of Selected Solid Tumors Abstracts.mp4\u003cbr\u003ePlatform Presentations of Selected Technical Topics Abstracts.mp4\u003cbr\u003ePost-Pandemic Molecular Diagnostics Opportunity, Strategy, and Mechanisms.mp4\u003cbr\u003ePotential impact of NGS in Clinical Microblology.mp4\u003cbr\u003eProfiling the Tumor Microenvironment and it’s Implications on Cancer Staging and Therapeutics.mp4\u003cbr\u003ePRospective Outcomes Molecular Implementation Support Registry (PROMISRx).mp4\u003cbr\u003eQIAGEN is pleased to welcome.mp4\u003cbr\u003eRecommendations for the Use of In silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation.mp4\u003cbr\u003eSARS CoV-2 Sequencing Utiilizing Variant Data to Predict The Next Wave.mp4\u003cbr\u003eSeegene Corporate Workshop.mp4\u003cbr\u003eSingle Cell Multi-Omics \u0026amp; the MRD Horizon.mp4\u003cbr\u003eStandardization of Bioinformatics Pipelines and Gene Product Nomenclature.mp4\u003cbr\u003eTechnologist Innovation Session.mp4\u003cbr\u003eTelomeres and telomerase in disease.mp4\u003cbr\u003eThe most comprehensive view of the genome at the scale and flexibility you need.mp4\u003cbr\u003eTrusted Answers.mp4\u003cbr\u003eUse of New Technologies Towards Clinical Applications.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954488676450,"sku":"MED-AMB04386","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Association-for-Molecular-Pathology-Annual-Meeting-Expo-2022.png?v=1779377801","url":"https:\/\/meducourse.com\/products\/association-for-molecular-pathology-annual-meeting-expo-2022","provider":"Meducourse","version":"1.0","type":"link"}